Pfizer Is Still Struggling to Replace Its COVID Revenue. Here's What We Could See From the Pharmaceutical Giant in 2026. Keep ...
A 2025 report from a bipartisan, congressionally chartered commission warns that China is closing in on a win, and the United ...
Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical biotechnology company with a robust pipeline of investigational ...
A recent breast cancer vaccine brings good news for women. The jab could help prevent Triple-negative breast cancer (TNBC) ...
These companies could innovate their way to success.
The Slovak Spectator on MSN
Award-winning chemist: No need to fear chemistry
Chemist Michal Májek, who not long ago received another ERC grant for Slovakia, said that the country has a tradition of ...
Should F-15E aircraft get transferred from Air Force bases like Seymour Johnson in North Carolina, it’ll come with a ...
Grist reports on Dawn, a Yorkshire pig, whose fat contributes to plant-based meat alternatives, blending plant proteins with ...
Kymera Therapeutics, Inc. KYMR recently announced that the FDA granted Fast Track designation to pipeline candidate KT-621 ...
Udemy , a global AI-powered skills acceleration platform, today unveiled a suite of new instructor-focused offerings, reinforcing the essential role of human expertise in an era reshaped by artificial ...
KOMZIFTI (ziftomenib), the first and only once-daily oral menin inhibitor for adult patients with R/R AML with a susceptible NPM1 mutation who have no satisfactory alternative treatment options, has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback